Literature DB >> 32574686

64Cu-labeled melanin nanoparticles for PET/CT and radionuclide therapy of tumor.

Huijun Zhou1, Qing Zhang2, Yan Cheng3, Lili Xiang4, Guohua Shen5, Xiaoai Wu5, Huawei Cai5, Daifeng Li6, Hua Zhu7, Ruiping Zhang8, Lin Li9, Zhen Cheng10.   

Abstract

Melanin is a group of natural pigments found in living organism. It can be used for positron emission tomography (PET) imaging due to its inherent chelating ability to radioactive cupric ion. This study was to prepare 64Cu-labeled PEGylated melanin nanoparticles (64Cu-PEG-MNPs), and to further take advantage of the enhanced permeability and retention (EPR) effect of radiolabeled nanoparticles to realize the integration of tumor diagnosis and treatment. We successfully synthesized PEG-MNPs. Saline and serum stability experiments demonstrated good stability. PET/CT showed high tumor aggregation. Moreover, 64Cu-PEG-MNPs resulted in a therapeutic effect on the A431 tumor-bearing mice in the treatment group. The pathological results further confirmed that the therapeutic doses of 64Cu-PEG-MNPs cause pathological changes of tumor tissues while showing minimal toxicity to normal tissues. Our data successfully demonstrate the good imaging performance of 64Cu-PEG-MNPs on A431 tumors and further proved its therapeutic effect, highlighting a great potential in targeted radionuclide therapy.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  (64)Cu; Imaging agent; Melanin nanoparticles; PET/CT; Radionuclide therapy

Mesh:

Substances:

Year:  2020        PMID: 32574686      PMCID: PMC7986290          DOI: 10.1016/j.nano.2020.102248

Source DB:  PubMed          Journal:  Nanomedicine        ISSN: 1549-9634            Impact factor:   5.307


  44 in total

1.  Contribution of Kupffer cells to liposome accumulation in the liver.

Authors:  Emma Samuelsson; Haifa Shen; Elvin Blanco; Mauro Ferrari; Joy Wolfram
Journal:  Colloids Surf B Biointerfaces       Date:  2017-07-15       Impact factor: 5.268

2.  (2S)-2-(3-(1-Carboxy-5-(4-211At-Astatobenzamido)Pentyl)Ureido)-Pentanedioic Acid for PSMA-Targeted α-Particle Radiopharmaceutical Therapy.

Authors:  Ana P Kiess; Il Minn; Ganesan Vaidyanathan; Robert F Hobbs; Anders Josefsson; Colette Shen; Mary Brummet; Ying Chen; Jaeyeon Choi; Eftychia Koumarianou; Kwamena Baidoo; Martin W Brechbiel; Ronnie C Mease; George Sgouros; Michael R Zalutsky; Martin G Pomper
Journal:  J Nucl Med       Date:  2016-05-26       Impact factor: 10.057

3.  Therapeutic efficacy of a 188Re-labeled alpha-melanocyte-stimulating hormone peptide analog in murine and human melanoma-bearing mouse models.

Authors:  Yubin Miao; Nellie K Owen; Darrell R Fisher; Timothy J Hoffman; Thomas P Quinn
Journal:  J Nucl Med       Date:  2005-01       Impact factor: 10.057

4.  Ion-exchange and adsorption of Fe(III) by Sepia melanin.

Authors:  Yan Liu; Lian Hong; Valerie R Kempf; Kazumasa Wakamatsu; Shosuke Ito; John D Simon
Journal:  Pigment Cell Res       Date:  2004-06

Review 5.  Nanoparticle-liver interactions: Cellular uptake and hepatobiliary elimination.

Authors:  Yi-Nan Zhang; Wilson Poon; Anthony J Tavares; Ian D McGilvray; Warren C W Chan
Journal:  J Control Release       Date:  2016-01-13       Impact factor: 9.776

6.  Current understanding of the binding sites, capacity, affinity, and biological significance of metals in melanin.

Authors:  Lian Hong; John D Simon
Journal:  J Phys Chem B       Date:  2007-06-20       Impact factor: 2.991

7.  Radiopharmaceutical therapy of patients with metastasized melanoma with the melanin-binding benzamide 131I-BA52.

Authors:  Walter Mier; Clemens Kratochwil; Jessica C Hassel; Frederik L Giesel; Barbro Beijer; John W Babich; Matthias Friebe; Michael Eisenhut; Alexander Enk; Uwe Haberkorn
Journal:  J Nucl Med       Date:  2013-11-25       Impact factor: 10.057

8.  Biokinetic and dosimetric aspects of 64CuCl2 in human prostate cancer: possible theranostic implications.

Authors:  Sergio Righi; Martina Ugolini; Gianluca Bottoni; Matteo Puntoni; Massimiliano Iacozzi; Francesco Paparo; Manlio Cabria; Luca Ceriani; Monica Gambaro; Luca Giovanella; Arnoldo Piccardo
Journal:  EJNMMI Res       Date:  2018-03-01       Impact factor: 3.138

9.  Rapid Hepatobiliary Excretion of Micelle-Encapsulated/Radiolabeled Upconverting Nanoparticles as an Integrated Form.

Authors:  Hyo Jung Seo; Sang Hwan Nam; Hyung-Jun Im; Ji-yong Park; Ji Youn Lee; Byeongjun Yoo; Yun-Sang Lee; Jae Min Jeong; Taeghwan Hyeon; Ji Who Kim; Jae Sung Lee; In-Jin Jang; Joo-Youn Cho; Do Won Hwang; Yung Doug Suh; Dong Soo Lee
Journal:  Sci Rep       Date:  2015-10-23       Impact factor: 4.379

10.  Efficacy and Safety of High-Specific-Activity 131I-MIBG Therapy in Patients with Advanced Pheochromocytoma or Paraganglioma.

Authors:  Daniel A Pryma; Bennett B Chin; Richard B Noto; Joseph S Dillon; Stephanie Perkins; Lilja Solnes; Lale Kostakoglu; Aldo N Serafini; Miguel H Pampaloni; Jessica Jensen; Thomas Armor; Tess Lin; Theresa White; Nancy Stambler; Stuart Apfel; Vincent A DiPippo; Syed Mahmood; Vivien Wong; Camilo Jimenez
Journal:  J Nucl Med       Date:  2018-10-05       Impact factor: 10.057

View more
  5 in total

Review 1.  Radiolabeled nanomaterials for biomedical applications: radiopharmacy in the era of nanotechnology.

Authors:  Martha Sahylí Ortega Pijeira; Herlys Viltres; Jan Kozempel; Michal Sakmár; Martin Vlk; Derya İlem-Özdemir; Meliha Ekinci; Seshasai Srinivasan; Amin Reza Rajabzadeh; Eduardo Ricci-Junior; Luciana Magalhães Rebelo Alencar; Mohammed Al Qahtani; Ralph Santos-Oliveira
Journal:  EJNMMI Radiopharm Chem       Date:  2022-04-25

2.  Highly Efficient Separation of Ultratrace Radioactive Copper Using a Flow Electrolysis Cell.

Authors:  Yumi Sugo; Shin-Ichi Ohira; Hinako Manabe; Yo-Hei Maruyama; Naoaki Yamazaki; Ryoma Miyachi; Kei Toda; Noriko S Ishioka; Masanobu Mori
Journal:  ACS Omega       Date:  2022-04-27

3.  NIR-Mediated drug release and tumor theranostics using melanin-loaded liposomes.

Authors:  Min Ah Kim; Chang-Moon Lee
Journal:  Biomater Res       Date:  2022-06-03

Review 4.  Highlight selection of radiochemistry and radiopharmacy developments by editorial board.

Authors:  Silvio Aime; Mohammed Al-Qahtani; Martin Behe; Guy Bormans; Giuseppe Carlucci; Jean N DaSilva; Clemens Decristoforo; Adriano Duatti; Philip H Elsinga; Klaus Kopka; Xiang-Guo Li; Zhibo Liu; Robert H Mach; Oskar Middel; Jan Passchier; Marianne Patt; Ivan Penuelas; Ana Rey; Peter J H Scott; Sergio Todde; Jun Toyohara; Danielle Vugts; Zhi Yang
Journal:  EJNMMI Radiopharm Chem       Date:  2021-03-18

Review 5.  Nanomaterial Probes for Nuclear Imaging.

Authors:  Vanessa Jing Xin Phua; Chang-Tong Yang; Bin Xia; Sean Xuexian Yan; Jiang Liu; Swee Eng Aw; Tao He; David Chee Eng Ng
Journal:  Nanomaterials (Basel)       Date:  2022-02-09       Impact factor: 5.076

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.